Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Blood Cancer Journal|August 19, 2024
Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activityJudith Lind, Osman Aksoy, Michaela Prchal-Murphy, et al.
Blood|August 27, 2014
Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesisEsther Rodríguez-Díez, Victor Quereda, Florian Bellutti, et al.
The Journal of Allergy and Clinical Immunology|October 11, 2019
Human signal transducer and activator of transcription 5b (STAT5b) mutation causes dysregulated human natural killer cell maturation and impaired lytic functionAlexander Vargas-Hernández, Agnieszka Witalisz-Siepracka, Michaela Prchal-Murphy, et al.
Blood|October 25, 2014
CDK6 as a key regulator of hematopoietic and leukemic stem cell activationRuth Scheicher, Andrea Hoelbl-Kovacic, Florian Bellutti, et al.
Oncoimmunology|October 21, 2016
Novel non-canonical role of STAT1 in Natural Killer cell cytotoxicityEva Maria Putz, Andrea Majoros, Dagmar Gotthardt, et al.
Cancer Science|February 10, 2021
ASK1 suppresses NK cell-mediated intravascular tumor cell clearance in lung metastasisMakoto Fujimoto, Miki Kamiyama, Kosuke Fuse, et al.
Plos One|June 23, 2012
TYK2 kinase activity is required for functional type I interferon responses in vivoMichaela Prchal-Murphy, Christian Semper, Caroline Lassnig, et al.
Cancer Discovery|February 14, 2016
STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor PromotionDagmar Gotthardt, Eva M Putz, Eva Grundschober, et al.
Pageof 4